Dan Shen: Benefits, Side Effects, and Uses

Gain a complete understanding of Dan Shen, bridging its traditional wisdom with modern scientific discoveries and essential usage guidelines.

Dan Shen, the dried root of Salvia miltiorrhiza, is one of the most widely used herbs in traditional Chinese medicine and has accumulated a substantial body of modern pharmacological research. Its two main classes of bioactive compounds, tanshinones and salvianolic acids, show effects across cardiovascular, neurological, liver, and kidney systems in laboratory and clinical studies. The herb also carries real risks, particularly for people on blood-thinning medications, and its key compounds are surprisingly hard for the body to absorb when taken by mouth.

What Is in the Root

Dan Shen’s pharmacological activity traces back to two chemical families. The first is the tanshinones, a group of fat-soluble compounds that include tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone. The second is the salvianolic acids, which are water-soluble phenolic acids, with salvianolic acid B and danshensu (also called salvianic acid A) being the most studied. These two classes work through different mechanisms and dissolve differently, which matters for how the herb is prepared and administered. Tanshinones tend to be extracted with alcohol or oil-based solvents, while salvianolic acids dissolve readily in water, making them prominent in aqueous decoctions and injectable preparations.

Heart and Blood Vessel Effects

The cardiovascular area is where Dan Shen has the deepest research base. Multiple laboratory studies show that tanshinone IIA relaxes blood vessels by stimulating the production of nitric oxide in the cells lining artery walls. One study found that tanshinone applied directly to small arteries in a hamster model nearly doubled the local concentration of nitric oxide and increased vessel diameter substantially. When researchers blocked the enzyme responsible for making nitric oxide, the vessel-relaxing effect disappeared, confirming that the mechanism runs through nitric oxide production. A 2024 study identified an additional channel involved in this process: tanshinone IIA activates a specific ion channel (TRPV4) on blood vessel lining cells, which in turn boosts nitric oxide output and triggers vessel relaxation through a downstream signaling cascade.

Beyond vessel relaxation, Dan Shen compounds appear to work against the buildup of arterial plaque. Tanshinone IIA reduced the formation of foam cells, the lipid-gorged immune cells that drive atherosclerosis, primarily by boosting the removal of cholesterol from those cells rather than by blocking cholesterol uptake. A review of the broader pharmacology noted that Dan Shen may slow atherosclerosis development, reduce blood pressure, and inhibit platelet clumping, all of which are relevant to preventing heart attacks and strokes.

Clinical Evidence for Angina

Most of the human clinical data on Dan Shen comes from studies using Compound Danshen Dripping Pills (CDDP), a widely prescribed formulation in China that combines Dan Shen extract with notoginseng and borneol. A review of clinical trials found that patients with stable angina who received CDDP experienced reduced pain intensity and fewer ischemic episodes compared with control groups. The pills appeared to improve blood flow properties and influence markers of inflammation, lowering C-reactive protein and endothelin-1 while raising nitric oxide levels.

A separate network meta-analysis compared several Dan Shen-based injections used alongside standard treatment for coronary heart disease. Different formulations showed strengths in different areas: some were better at reducing inflammatory markers, others at improving antioxidant levels. Broadly, adding a Dan Shen injection to conventional therapy appeared to improve clinical outcomes compared with conventional therapy alone. It is worth noting that much of this clinical evidence comes from Chinese hospital settings using injectable formulations, and the results may not directly translate to oral supplements sold in Western markets.

Brain and Stroke Protection

When blood flow to part of the brain is blocked and then restored, the resulting “reperfusion injury” often causes significant damage through inflammation and oxidative stress. Dan Shen injection reduced brain infarction size and improved neurological scores in rats with experimentally induced strokes. The mechanism appeared to involve suppressing a chain of inflammatory signals: the injection decreased levels of key pro-inflammatory proteins and oxidative stress markers in brain tissue.

Interestingly, danshensu (one of the water-soluble compounds) showed synergistic neuroprotective effects when combined with hydroxysafflor yellow A, a compound from safflower, another herb commonly paired with Dan Shen in traditional formulas. Together, the two compounds reduced inflammation and oxidative stress more effectively than either one alone, both in live animals and in laboratory neuron cultures. This is consistent with the traditional Chinese medicine approach of using herbs in multi-ingredient formulas rather than isolation, though it also makes it harder to attribute benefits to Dan Shen alone.

Liver Protection and Anti-Fibrotic Effects

Liver fibrosis, the scarring that precedes cirrhosis, is driven by the activation of specialized cells called hepatic stellate cells. When these cells switch from a resting state to an active, scar-producing state, the liver progressively stiffens and loses function. Dan Shen compounds inhibited the growth and activity of these stellate cells in laboratory studies, suppressing the production of collagen and other fibrosis-related proteins.

More recent work has explored the specific mechanism. Danshensu reversed the activation of stellate cells that had been triggered by palmitic acid, a saturated fat. The compound worked partly by regulating a form of programmed cell death called pyroptosis in those activated cells, reducing the expression of inflammatory markers that drive the fibrotic process. These findings are all preclinical, so whether Dan Shen supplements meaningfully help people with liver fibrosis remains unproven, but the consistency of the laboratory evidence has made it a popular area of investigation.

Kidney Disease and Diabetic Nephropathy

Kidney damage from diabetes is one of the most common microvascular complications of the disease, affecting roughly a fifth to two-fifths of diabetic patients and frequently progressing toward end-stage kidney failure. In diabetic rat models, Dan Shen injection reduced elevated creatinine and blood urea nitrogen levels, markers of declining kidney function. It also appeared to protect the physical structure of kidney tissue, reducing swelling and dilation of the tiny filtering units and tubules.

Separately, danshensu protected kidney tissue against damage from cisplatin, a chemotherapy drug notorious for causing kidney injury. The compound improved markers of kidney function, reduced inflammation, and boosted antioxidant defenses in cisplatin-treated animals. A similar protective pattern, working through the same antioxidant pathway, was confirmed by another research group using a different experimental setup. The kidney evidence is still entirely from animal models, so people with kidney disease should not treat Dan Shen as a substitute for established therapies.

Antioxidant and Anti-Inflammatory Mechanisms

A thread running through nearly all of Dan Shen’s studied effects is its ability to reduce oxidative stress and suppress inflammation. In the heart, brain, liver, and kidneys, the same broad pattern shows up: Dan Shen compounds boost the body’s internal antioxidant enzymes and tamp down inflammatory signaling molecules. Danshensu, for instance, protected isolated hearts from reperfusion damage by activating a signaling cascade that enhances the body’s own antioxidant defense system, increasing the activity of protective enzymes like superoxide dismutase and catalase.

Dan Shen compounds also modulate immune responses more broadly. Tanshinones and salvianolic acids have been shown to influence the function and numbers of various immune cells, the growth of immune organs, and the release of immune signaling molecules. Whether this immune-modulating activity is beneficial or problematic depends on context. For people with excessive inflammation, it could be helpful. For people on immunosuppressive drugs, it introduces unpredictability.

Cancer Research

Cryptotanshinone, one of the tanshinones in Dan Shen, has shown the ability to inhibit the growth and spread of several types of cancer cells in laboratory settings. The compound appears to interfere with multiple pathways that cancer cells rely on for survival and proliferation, promoting programmed cell death and inhibiting migration and invasion of tumor cells. This is early-stage research, and the gap between killing cancer cells in a dish and treating cancer in a person is enormous. No clinical trials have established Dan Shen or its isolated compounds as cancer treatments, and the herb should not be used as an alternative to oncology care.

The Bioavailability Problem

One of the biggest challenges with Dan Shen is that its most studied compound, tanshinone IIA, is very poorly absorbed when taken by mouth. Studies in rats found that oral bioavailability sits at roughly 3 to 3.5 percent, meaning the vast majority of what you swallow never makes it into the bloodstream. The problem is twofold: tanshinone IIA dissolves very poorly in water, and a transport protein in the gut wall actively pumps it back into the intestine after it crosses the lining. On top of that, whatever small amount does get absorbed faces extensive first-pass metabolism in the liver.

This matters for consumers because many of the impressive laboratory results use concentrations of tanshinone IIA that oral supplements may never achieve in the blood. Researchers are developing nanoparticle and lipid-based delivery systems to improve absorption, but these are not yet standard in commercially available products. Injectable formulations used in Chinese hospitals bypass the gut entirely, which is one reason the clinical results from injectable Dan Shen studies may not apply to capsules or teas. The water-soluble salvianolic acids are generally better absorbed, which is worth keeping in mind when choosing a preparation.

Drug Interactions and Side Effects

The most serious and well-documented interaction involves warfarin, the blood thinner. Dan Shen increased both the absorption and the half-life of warfarin in animal studies, meaning the drug lingered in the body longer and reached higher concentrations. The practical result was dramatically exaggerated anticoagulation. Case reports have documented bleeding complications in patients who combined the two. This is not a theoretical concern; it is a clinically observed danger. If you take warfarin or any other anticoagulant, Dan Shen should be avoided unless your doctor is actively monitoring the combination.

The interaction risk extends beyond warfarin. Tanshinones inhibit several liver enzymes responsible for metabolizing drugs. In laboratory tests using human liver preparations, they were potent inhibitors of CYP1A2 and moderate inhibitors of CYP2C9, with weaker effects on other enzymes. Dihydrotanshinone was particularly strong against CYP2C9. These enzymes process a wide range of medications, including some antidepressants, anti-seizure drugs, certain painkillers, and cardiovascular medications. Inhibiting them can cause other drugs to accumulate to higher-than-intended levels. Anyone on prescription medications should discuss Dan Shen use with a pharmacist or physician.

Side effects of Dan Shen itself are generally mild in the reported clinical literature. Gastrointestinal discomfort, dizziness, and allergic reactions have been noted. Because the herb has antiplatelet and blood-thinning properties on its own, it can increase bleeding risk even without warfarin in the picture, particularly around surgery or in people with bleeding disorders.

Common Formulations and How They Differ

Dan Shen rarely appears as a single-herb preparation in clinical practice. The most widely studied formulation is the Compound Danshen Dripping Pill, which combines Dan Shen with notoginseng (Panax notoginseng) and borneol. This combination has gone through formal clinical trials for angina and has completed a Phase III trial for regulatory consideration outside China. The Dan Shen-notoginseng pairing has shown synergistic effects in cell studies, with specific ratios of the two herbs producing better endothelial cell protection than either herb alone.

Dan Shen injections, used intravenously in hospitals, are another major category. These bypass absorption issues entirely and have been the basis for much of the clinical evidence. A third category includes simple dried root preparations, teas, and powdered capsules available in supplement stores. These products vary enormously in their chemical profiles.

Quality and Contamination Concerns

A study examining sixty Dan Shen samples from global markets found real quality control issues. Substitutes for genuine Salvia miltiorrhiza and different processing methods are common enough to raise safety concerns. More troubling, about one in ten samples exceeded cadmium limits set by pharmacopeial standards, and the more processing a product had undergone, the higher the likelihood of heavy metal contamination, particularly for arsenic and cadmium. Concentrated extracts showed more contamination than raw materials, suggesting the concentration process may also concentrate unwanted metals. For consumers, this means the source and manufacturing practices of a Dan Shen product matter quite a bit, and choosing products that have been independently tested is more than just a nice idea.

Traditional Uses Beyond the Heart

In traditional Chinese medicine, Dan Shen’s uses extend well beyond what modern cardiology research focuses on. It has historically been classified as a herb that “activates blood and dispels stasis,” placing it in a category used for menstrual irregularities, chest pain, abdominal masses, and insomnia with restlessness. Its traditional action on the liver and its role in addressing “blood stasis” led to its use for bone health conditions as well. In TCM theory, osteoporosis is linked to liver dysfunction and stagnant blood circulation, and Dan Shen has been used as part of anti-osteoporotic formulas on that basis. Some of these traditional applications have modern parallels in the laboratory data, and others remain unexplored by contemporary research methods.

One area where traditional use and modern evidence diverge somewhat is dosing. Traditional decoctions typically use 9 to 15 grams of dried root simmered in water, which primarily extracts the water-soluble salvianolic acids. Modern concentrated supplements and injectable forms deliver a different chemical profile at different doses. Consumers often assume that a traditional recommendation can be directly translated to a modern extract, but the two can be chemically quite different products even though they share a name on the label.